Mounjaro and reflux: what clinical evidence and patient reports tell us

What the trial data show about reflux and indigestion on tirzepatide

The SURMOUNT-1 trial, the largest placebo-controlled study of tirzepatide for weight management (2,539 adults over 72 weeks, published in the New England Journal of Medicine), recorded gastrointestinal events as the most frequently reported adverse effects across all treatment groups. Nausea, vomiting, diarrhoea and constipation attracted the most attention, but indigestion (which covers the burning and regurgitation that most people mean when they say reflux) was also documented.

The NHS patient-facing information for tirzepatide lists indigestion and burping as common side effects affecting more than one in a hundred people. That classification means they are frequent enough to appear consistently across the trial data rather than being rare one-off reports.

The mechanism is not mysterious. Tirzepatide activates both GIP and GLP-1 receptors, which slows the rate at which food moves from your stomach into the small intestine. A fuller, slower stomach raises intragastric pressure. If that pressure is high enough, it can push contents back through the lower oesophageal sphincter, the muscular valve that is supposed to keep acid in your stomach. The result is the familiar burning or sour taste of acid reflux, and if you are wondering does Mounjaro cause reflux in everyone or only some people, the short answer is that it depends on individual physiology and dose. Understanding that this is a physiological effect of the medicine (not a sign something has gone wrong with your digestion permanently) helps frame how to manage it.

When reflux on Mounjaro is most likely to appear

Timing matters. The majority of people who notice reflux on Mounjaro report it in the first two to three weeks after starting a new dose, when the slowing effect on gastric emptying is at its most pronounced relative to what the body is used to. The SURMOUNT programme found that gastrointestinal side effects were most common around dose increases and tended to lessen as participants stayed at a stable dose.

This pattern has a practical implication: if your reflux began shortly after moving from one dose to the next, it may well resolve without any change to your treatment. That does not mean you should ignore it. Reflux that disrupts sleep, makes eating difficult, or feels severe warrants a conversation with your prescriber rather than waiting it out alone.

A quick check worth building into your routine: before your weekly injection, note whether your reflux has eased compared with the week before. If it is trending downward, the body is likely adjusting on schedule. If it has stayed the same or worsened for more than two to three weeks at the same dose, that is worth flagging. Takes under a minute and gives your prescriber genuinely useful information.

People who had pre-existing gastro-oesophageal reflux disease (GORD) before starting Mounjaro sometimes find their symptoms become temporarily more pronounced. This is one of the reasons a thorough medical history is part of the clinical assessment before treatment begins. Our overview of Mounjaro side effects covers the broader gastrointestinal picture beyond reflux specifically.

Practical steps that reduce reflux without pausing treatment

Because reflux on Mounjaro is driven by slower gastric emptying, changes to eating habits address the root cause more directly than simply reaching for antacids. Smaller, more frequent meals reduce the volume of food in the stomach at any one time, which lowers the pressure that drives reflux. Eating slowly also matters: tirzepatide already extends the feeling of fullness, so eating past that signal tends to worsen symptoms noticeably.

Fatty, spicy or highly acidic foods are established reflux triggers for many people regardless of medication, and they become more likely to cause problems when gastric emptying is slowed. Carbonated drinks introduce gas that adds to intragastric pressure and are worth cutting back while the body is adjusting. Staying upright for at least two to three hours after eating gives the stomach more time to begin emptying before you lie down.

Elevating the head of the bed by around 15–20 centimetres using a wedge pillow or raised bed frame (not extra pillows, which bend the body at the waist and can make things worse) is one of the more effective overnight measures endorsed by NHS guidance on managing acid reflux. Our guide to Mounjaro acid reflux goes into detail on why the medicine triggers these symptoms and what the evidence says about managing them alongside treatment. You can read more about stopping acid reflux on Mounjaro in our dedicated guide: how to manage reflux on Mounjaro.

If lifestyle adjustments are not sufficient, some prescribers consider short-term acid-suppressing medication alongside tirzepatide. That decision sits with your prescriber, who can weigh it against your full medical history. Our complete Mounjaro information page explains the medicine's mechanism and licensed use in full, and there is a more detailed look at the tirzepatide and reflux relationship if you want to explore the pharmacology further.

When to get medical help

Most reflux on Mounjaro is uncomfortable rather than dangerous, but a small number of symptoms need prompt attention. Severe, persistent stomach pain that radiates to your back (with or without vomiting) should be assessed urgently, as this can be a sign of pancreatitis. In January 2026, the MHRA's Yellow Card reporting system was cited in updated prescribing guidance highlighting acute pancreatitis as an infrequent but serious effect of GLP-1 medicines. It is not the same sensation as typical reflux, but it is worth knowing about.

Other symptoms that warrant medical attention rather than watchful waiting: difficulty swallowing, vomiting blood or material that looks like coffee grounds, unexplained weight loss beyond what the treatment would account for, or reflux that has not improved after several weeks at a stable dose despite reasonable lifestyle changes.

You can report any suspected side effects from Mounjaro directly at yellowcard.mhra.gov.uk. If you have further questions about how reflux fits into your specific treatment plan, or you are considering starting Mounjaro and have a history of GORD, our prescribers are available seven days a week. Speak to our prescribers through a free consultation and get a personalised clinical view rather than a general answer.